Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Lymphoma, Non-Hodgkin lymphoma (NHL), Secondary cancers
Closed
Phase 2
This trial is for people with a type of lymphoma that started in the T cells of the skin. It is called cutaneous T cell lymphoma (CTCL).
It is for people with CTCL that has come back or got worse after at least one type of treatment that reached the whole body (systemic).
Recruitment start: 15 January 2019
Recruitment end: 31 December 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Illidge
University College London (UCL)
Merck Sharp & Dohme
Last reviewed: 30 Dec 2022
CRUK internal database number: 15561
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
